Preparation method of terbutaline sulfate and B crystal form thereof

A technology of terbutaline sulfate and crystal form, which is applied in the field of chemical drug synthesis, can solve the problems of easy oxidation and deterioration of hydroxyl groups, fewer reaction steps, and high cost, and achieve industrial production, mild reaction conditions, and short reaction routes.

Pending Publication Date: 2021-01-22
NINGBO TEAM PHARMA
View PDF8 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This route has fewer reaction steps and higher yield, but the unprotected hydroxyl group directly undergoes bromination reaction, the hydroxyl group is easy to oxidize and deteriorate, and the treatment after sodium borohydride reduction is also relatively cumbersome, so the industrial application prospect of this method is not great;
[0008] (4) Chinese patent application CN201310560213.5 uses commercially available bambuterol hydrochloride as a raw material, and terbutaline sulfate can be obtained only after hydrolysis and salification. The route is simple, the yield is high, the operation is convenient, and the environmental pressure is small , but the raw material bambuterol hydrochloride is expensive, the cost is too high, and the industrialized products are not competitive
At present, the reports on terbutaline sulfate are mainly based on the synthetic route, and there are few reports on the preparation of its medicinal B crystal form

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of terbutaline sulfate and B crystal form thereof
  • Preparation method of terbutaline sulfate and B crystal form thereof
  • Preparation method of terbutaline sulfate and B crystal form thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] In the present embodiment, the preparation method of terbutaline sulfate and its medicinal B crystal form is as follows:

[0041] (1) Preparation of 1-[3,5-bis(benzyloxy)phenyl]-2-bromoethanol

[0042]At room temperature, add 100.0g (300.84mmol) of 3,5-dibenzyloxyacetophenone and 800mL of dichloromethane into the reaction vessel, stir to dissolve, add 141.1g (631.77mmol) of copper bromide, and stir under reflux for 3h. The reaction solution was suction filtered, the filtrate was washed with concentrated hydrochloric acid, and the organic layer was evaporated under reduced pressure to remove dichloromethane. Add 500mL methanol to the residue, stir and cool down to 10-15°C, add 16.3g (300.84mmol) potassium borohydride under temperature control, after the addition is complete, keep stirring for 1h. After adding 100mL of water, continue to stir for 30min, filter with suction, and wash the filter cake with water to obtain 121.8g of off-white solid, namely 1-[3,5-bis(benzylo...

Embodiment 2

[0055] The preparation method of present embodiment terbutaline sulfate and pharmaceutical B crystal form thereof is:

[0056] (1) Preparation of 1-[3,5-bis(benzyloxy)phenyl]-2-bromoethanol

[0057] At room temperature, add 100.0g (300.84mmol) of 3,5-dibenzyloxyacetophenone and 1L of chloroform into the reaction vessel, stir and dissolve, then add 72.1g (451.26mmol) of bromine dropwise at 20-25°C, After dropping, the temperature was raised to reflux and stirred for 1 h. The reaction solution was evaporated under reduced pressure to remove chloroform. Add 500mL methanol to the residue, stir and cool down to 10-15°C, add 17.1g (451.26mmol) sodium borohydride under temperature control, after the addition is complete, keep stirring for 1h. After adding 100mL of water, continue to stir for 30min, filter with suction, and wash the filter cake with water to obtain 109.4g of off-white solid, that is, 1-[3,5-bis(benzyloxy)phenyl]-2-bromoethanol, yield 88 %.

[0058] (2) Preparation...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
crystallization temperatureaaaaaaaaaa
Login to view more

Abstract

The invention relates to a preparation method of terbutaline sulfate and a B crystal form thereof, which comprises the following steps: sequentially carrying out bromination, reduction reaction and substitution reaction to obtain 1-[3, 5-bis (benzyloxy) phenyl]-2-(tert-butylamino) ethanol; reacting 1-[3, 5-di (benzyloxy) phenyl]-2-(tert-butylamino) ethanol with a reducing agent and a catalyst, performing salifying with sulfuric acid to obtain a terbutaline sulfate crude product, and crystallizing the terbutaline sulfate crude product under a heating reflux condition to obtain the terbutaline sulfate medicinal B crystal form. Raw materials and auxiliary materials used in the method are cheap and easy to obtain, highly toxic and explosive reagents are avoided in the reaction process, the whole reaction route is short, operation is easy and convenient, reaction conditions are mild and safe, the yield of the obtained finished product terbutaline sulfate and the medicinal B crystal form thereof is high, the yield of terbutaline sulfate is 83% or above, and the yield of the medicinal B crystal form is 70% or above, and industrialized production can be achieved easily.

Description

technical field [0001] The invention relates to the technical field of chemical drug synthesis, in particular to a preparation method of terbutaline sulfate and its B crystal form. Background technique [0002] Terbutaline Sulfate, also known as hydroxyalbutaline, can selectively stimulate β2 receptors to relax bronchial smooth muscle. Clinically, it is mainly used for bronchial asthma, asthmatic bronchitis and chronic obstructive pulmonary disease. treatment of bronchospasm. It was first developed by AstraZeneca Pharmaceutical Co., Ltd., and it was produced and marketed abroad in 1988. This product is soluble in water, slightly soluble in methanol, almost insoluble in chloroform. [0003] At present, there are few literature reports on the synthesis routes of terbutaline sulfate, and these routes will have some problems in industrial application, such as expensive starting materials and difficult to obtain, lengthy process routes, cumbersome operations, and problems in un...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07C215/30C07C213/00C07C213/10C07C213/02C07C41/26C07C43/178
CPCC07C215/30C07C41/26C07C213/02C07C213/00C07C213/10C07B2200/13
Inventor 何鑫胡彬彬徐骥汪伟
Owner NINGBO TEAM PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products